/
BPTSY
$0.25+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $2.00
12% from low
Exchange
OTC Link
ADRC
Borrow rate
361.88%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-8.25
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $204.0K | $227.0K | $258.3K | $280.0K | $311.0K | $472.7K | $803.0K | $0 |
| Gross profit | −$204.0K | −$227.0K | −$258.3K | −$280.0K | −$311.0K | −$472.7K | −$803.0K | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $7.0M | $9.5M | $9.1M | $9.9M | $19.7M | $16.0M | $10.4M | $4.5M |
| Operating income | −$9.9M | −$13.9M | −$15.7M | −$13.9M | −$26.8M | −$23.3M | −$14.3M | −$8.5M |
| EBITDA | −$9.7M | −$13.6M | −$15.4M | −$13.7M | −$26.5M | −$22.8M | −$13.8M | −$8.3M |
| Net income | −$11.4M | −$14.0M | −$18.9M | −$25.5M | −$31.2M | −$24.2M | −$17.0M | −$10.4M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -4966.50 | -4183.20 | -4488.80 | -1701.90 | -1053.80 | -554.00 | -125.40 | -2.00 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2M | $-0.81 | $-0.81–$-0.81 | 1 |
| 2027 | $0 | $-0.81 | $-0.81–$-0.81 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
BIOPHYTIS SA SP/ADR
BIOPHYTIS SA SP/ADR
Held by traders on TradeandTell
No one on the platform currently holds BPTSY.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BPTSY as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BPTSY yet.